Hyperuricemia, pulmonary hypertension, renal failure, alkalosis syndrome
|
0.720 |
GeneticVariation
|
disease |
BEFREE |
Missense mutations in the mitochondrial seryl-tRNA synthetase gene, SARS2, have been identified in HUPRA syndrome (hyperuricemia, pulmonary hypertension, renal failure in infancy, and alkalosis).
|
27279129 |
2016 |
Hyperuricemia, pulmonary hypertension, renal failure, alkalosis syndrome
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
Hyperuricemia, pulmonary hypertension, renal failure, alkalosis syndrome
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Several data support that p.R402H mutation in SARS2 is a new cause of HUPRA syndrome.
|
24034276 |
2013 |
Hyperuricemia, pulmonary hypertension, renal failure, alkalosis syndrome
|
0.720 |
GeneticVariation
|
disease |
BEFREE |
Several data support that p.R402H mutation in SARS2 is a new cause of HUPRA syndrome.
|
24034276 |
2013 |
Hyperuricemia, pulmonary hypertension, renal failure, alkalosis syndrome
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Several data support that p.R402H mutation in SARS2 is a new cause of HUPRA syndrome.
|
24034276 |
2013 |
Hyperuricemia, pulmonary hypertension, renal failure, alkalosis syndrome
|
0.720 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutations in the mitochondrial seryl-tRNA synthetase cause hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis, HUPRA syndrome.
|
21255763 |
2011 |
Hyperuricemia, pulmonary hypertension, renal failure, alkalosis syndrome
|
0.720 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in the mitochondrial seryl-tRNA synthetase cause hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis, HUPRA syndrome.
|
21255763 |
2011 |
Hyperuricemia, pulmonary hypertension, renal failure, alkalosis syndrome
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in the mitochondrial seryl-tRNA synthetase cause hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis, HUPRA syndrome.
|
21255763 |
2011 |
Hyperuricemia, pulmonary hypertension, renal failure, alkalosis syndrome
|
0.720 |
Biomarker
|
disease |
CTD_human |
|
|
|
Hyperuricemia, pulmonary hypertension, renal failure, alkalosis syndrome
|
0.720 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Hyperuricemia
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the mitochondrial seryl-tRNA synthetase cause hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis, HUPRA syndrome.
|
21255763 |
2011 |
Respiratory Failure
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Infection of humans with the severe acute respiratory syndrome coronavirus (SARS-CoV) results in substantial morbidity and mortality, with death resulting primarily from respiratory failure.
|
18495771 |
2008 |
Hyperuricemia
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Respiratory Failure
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Severe Acute Respiratory Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We have reported on aristeromycin (1) and 6'-fluorinated-aristeromycin analogues (2), which are active against RNA viruses such as Middle East respiratory syndrome coronavirus (MERS-CoV), severe acute respiratory syndrome coronavirus (SARS-CoV), Zika virus (ZIKV), and Chikungunya virus (CHIKV).
|
31841728 |
2020 |
Middle East Respiratory Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
We have reported on aristeromycin (1) and 6'-fluorinated-aristeromycin analogues (2), which are active against RNA viruses such as Middle East respiratory syndrome coronavirus (MERS-CoV), severe acute respiratory syndrome coronavirus (SARS-CoV), Zika virus (ZIKV), and Chikungunya virus (CHIKV).
|
31841728 |
2020 |
Influenza
|
0.100 |
Biomarker
|
disease |
BEFREE |
In many instances these outbreaks have been newly emerging (SARS coronavirus), re-emerging (Ebola virus, Zika virus) or zoonotic (avian influenza H5N1) virus infections.
|
31771760 |
2019 |
Influenza
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Annual excess rates of mortality or hospitalization associated with influenza in the older population were estimated for the pre-SARS (reference period), post-SARS and post-pandemic period, respectively.
|
30764779 |
2019 |
Virus Diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
In many instances these outbreaks have been newly emerging (SARS coronavirus), re-emerging (Ebola virus, Zika virus) or zoonotic (avian influenza H5N1) virus infections.
|
31771760 |
2019 |
Hemorrhagic Fever, Ebola
|
0.100 |
Biomarker
|
disease |
BEFREE |
Like SARS previously and Zika recently, the Ebola crisis in 2015 showed how vulnerable the world is to these epidemics, with over 11,000 people dying in the outbreak.
|
29410084 |
2019 |
Hemorrhagic Fever, Ebola
|
0.100 |
Biomarker
|
disease |
BEFREE |
In many instances these outbreaks have been newly emerging (SARS coronavirus), re-emerging (Ebola virus, Zika virus) or zoonotic (avian influenza H5N1) virus infections.
|
31771760 |
2019 |
Severe Acute Respiratory Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
These emerging infections, including severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV) and the pandemic influenza A(H1N1) and avian influenza (AI) viruses, have seriously threatened global health and the economy.
|
30985968 |
2019 |
Severe Acute Respiratory Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Bats are the natural reservoirs of severe acute respiratory syndrome coronavirus (SARS-CoV) which caused the outbreak of human SARS in 2002-2003.
|
30735813 |
2019 |
Severe Acute Respiratory Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
The recent emergence of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) in humans, with evidence that these viruses may have their ancestry in bats, highlights the importance of virus surveillance in bat populations.
|
30426315 |
2019 |
Severe Acute Respiratory Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Newly emerging viruses, such as severe acute respiratory syndrome coronavirus (SARS-CoV), Middle Eastern respiratory syndrome CoVs (MERS-CoV), and H7N9, cause fatal acute lung injury (ALI) by driving hypercytokinemia and aggressive inflammation through mechanisms that remain elusive.
|
30830861 |
2019 |